Michael Cwik

1.3k total citations
30 papers, 947 citations indexed

About

Michael Cwik is a scholar working on Pharmacology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Michael Cwik has authored 30 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 8 papers in Molecular Biology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Michael Cwik's work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Analytical Methods in Pharmaceuticals (5 papers) and Pharmaceutical studies and practices (4 papers). Michael Cwik is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (8 papers), Analytical Methods in Pharmaceuticals (5 papers) and Pharmaceutical studies and practices (4 papers). Michael Cwik collaborates with scholars based in United States, Japan and Switzerland. Michael Cwik's co-authors include Timothy R. VadeBoncouer, Guy Weinberg, James H. Fischer, David L. McCormick, Jie Lu, Izet M. Kapetanović, Thomas Horn, Dale A. Pelligrino, Mark S. Luer and Robert L. Morrissey and has published in prestigious journals such as Cancer Research, Brain Research and Ophthalmology.

In The Last Decade

Michael Cwik

30 papers receiving 888 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Cwik United States 16 383 171 162 148 141 30 947
P. Sandouk France 19 257 0.7× 64 0.4× 307 1.9× 162 1.1× 226 1.6× 48 1.1k
Gerald Woollard New Zealand 17 314 0.8× 35 0.2× 230 1.4× 100 0.7× 294 2.1× 37 1.0k
Uğur Oral Türkiye 12 120 0.3× 91 0.5× 61 0.4× 121 0.8× 53 0.4× 20 734
F. O. Holley United States 10 189 0.5× 32 0.2× 304 1.9× 109 0.7× 151 1.1× 16 903
Rolf Terlinden Germany 17 286 0.7× 34 0.2× 380 2.3× 127 0.9× 116 0.8× 32 1.2k
J. E. Bredesen Norway 18 99 0.3× 293 1.7× 43 0.3× 139 0.9× 90 0.6× 48 918
Scott R. Hamann United States 16 78 0.2× 45 0.3× 63 0.4× 207 1.4× 146 1.0× 37 929
George D. Olsen United States 17 71 0.2× 45 0.3× 140 0.9× 137 0.9× 311 2.2× 41 824
Tomoaki Shimizu Japan 25 541 1.4× 72 0.4× 136 0.8× 401 2.7× 37 0.3× 90 2.2k
J. Nimmo United Kingdom 11 227 0.6× 66 0.4× 61 0.4× 65 0.4× 97 0.7× 16 916

Countries citing papers authored by Michael Cwik

Since Specialization
Citations

This map shows the geographic impact of Michael Cwik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Cwik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Cwik more than expected).

Fields of papers citing papers by Michael Cwik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Cwik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Cwik. The network helps show where Michael Cwik may publish in the future.

Co-authorship network of co-authors of Michael Cwik

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Cwik. A scholar is included among the top collaborators of Michael Cwik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Cwik. Michael Cwik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Shining, et al.. (2021). Safety, tolerability, pharmacokinetics, pharmacodynamics, bioavailability and food effect of single doses of soticlestat in healthy subjects. British Journal of Clinical Pharmacology. 87(11). 4354–4365. 22 indexed citations
2.
Chiappelli, Joshua, Maria S. Quinton, Dmitri Volfson, et al.. (2020). Assessment of brain cholesterol metabolism biomarker 24S-hydroxycholesterol in schizophrenia. Schizophrenia. 6(1). 34–34. 10 indexed citations
3.
Cwik, Michael, et al.. (2010). Direct quantitation of glucoraphanin in dog and rat plasma by LC–MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 52(4). 544–549. 20 indexed citations
4.
Horn, Thomas, Karen E. O. Torres, Michael Cwik, et al.. (2007). Subchronic Toxicity and Toxicogenomic Evaluation of Tamoxifen Citrate + Bexarotene in Female Rats. Toxicological Sciences. 99(2). 612–627. 10 indexed citations
5.
Horn, Thomas, Michael Cwik, Robert L. Morrissey, et al.. (2006). Oncogenicity evaluation of resveratrol in p53(±) (p53 knockout) mice. Food and Chemical Toxicology. 45(1). 55–63. 27 indexed citations
6.
Horn, Thomas, Lina Long, Michael Cwik, et al.. (2005). Modulation of hepatic and renal drug metabolizing enzyme activities in rats by subchronic administration of farnesol. Chemico-Biological Interactions. 152(2-3). 79–99. 31 indexed citations
7.
Gotfried, Mark H., Keith A. Rodvold, Michael Cwik, et al.. (2005). An open-label clinical evaluation of tigecycline (TGC) concentrations in selected tissues and fluids. Clinical Pharmacology & Therapeutics. 77(2). P98–P98. 6 indexed citations
8.
Bosland, Maarten C., William D. Johnson, Michael Cwik, et al.. (2004). Lack of chemopreventive activity of lycopene in the Wistar-Unilever rat prostate cancer model. Cancer Research. 64. 900–900. 3 indexed citations
9.
Fiscella, Richard G., Michael Cwik, Steven Friedlander, et al.. (1999). Aqueous and vitreous penetration of levofloxacin after oral administration11The authors have no financial interest in levofloxacin or in any other product mentioned in this article.. Ophthalmology. 106(12). 2286–2290. 50 indexed citations
10.
Wang, Qi, et al.. (1999). The In Vivo Unidirectional Conversion of Nitro-d-arginine to Nitro-l-arginine. Journal of Pharmacology and Experimental Therapeutics. 288(1). 270–273. 19 indexed citations
11.
Weinberg, Guy, et al.. (1998). Pretreatment or Resuscitation with a Lipid Infusion Shifts the Dose-Response to Bupivacaine-induced Asystole in Rats . Anesthesiology. 88(4). 1071–1075. 446 indexed citations
12.
Fischer, James H., et al.. (1997). Stability of Fosphenytoin Sodium with Intravenous Solutions in Glass Bottles, Polyvinyl Chloride Bags, and Polypropylene Syringes. Annals of Pharmacotherapy. 31(5). 553–559. 15 indexed citations
13.
Lu, Jie, Michael Cwik, & Thomas P. Kanyok. (1997). Determination of paromomycin in human plasma and urine by reversed-phase high-performance liquid chromatography using 2,4-dinitrofluorobenzene derivatization. Journal of Chromatography B Biomedical Sciences and Applications. 695(2). 329–335. 24 indexed citations
14.
Lu, Jie & Michael Cwik. (1997). Determination of capsaicin and zucapsaicin in human serum by high-performance liquid chromatography with fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 701(1). 135–139. 16 indexed citations
15.
Cwik, Michael, et al.. (1997). Simultaneous rapid high-performance liquid chromatographic determination of phenytoin and its prodrug, fosphenytoin in human plasma and ultrafiltrate. Journal of Chromatography B Biomedical Sciences and Applications. 693(2). 407–414. 21 indexed citations
16.
Cwik, Michael, et al.. (1996). Determination of Catecholamines in Human Plasma by HPLC with Electrochemical Detection. Journal of Liquid Chromatography & Related Technologies. 19(8). 1339–1348. 20 indexed citations
17.
Wang, Qiong, Dale A. Pelligrino, Verna L. Baughman, et al.. (1994). Nitric oxide (NO) is an endogenous anticonvulsant but not a mediator of the increase in cerebral blood flow accompanying bicuculline-induced seizures in rats. Brain Research. 658(1-2). 192–198. 54 indexed citations
18.
Kraus, Donna M., James H. Fischer, Susan Kecskes, et al.. (1993). Alterations in theophylline metabolism during the first year of life. Clinical Pharmacology & Therapeutics. 54(4). 351–359. 52 indexed citations
19.
Cunningham, Francesca, et al.. (1992). The pharmacokinetics of methocarbamol in the thoroughbred race horse. Journal of Veterinary Pharmacology and Therapeutics. 15(1). 96–100. 3 indexed citations
20.
Cwik, Michael, et al.. (1985). Quantitative determination of tolazoline in serum and urine. Journal of Chromatography B Biomedical Sciences and Applications. 338(1). 123–130. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Sandouk Breakdown of academic impact, for papers by Gerald Woollard Breakdown of academic impact, for papers by Uğur Oral Breakdown of academic impact, for papers by F. O. Holley Breakdown of academic impact, for papers by Rolf Terlinden Breakdown of academic impact, for papers by J. E. Bredesen Breakdown of academic impact, for papers by Scott R. Hamann Breakdown of academic impact, for papers by George D. Olsen Breakdown of academic impact, for papers by Tomoaki Shimizu Breakdown of academic impact, for papers by J. Nimmo
Rankless by CCL
2026